
    
      This is a double-blind, randomized placebo-controlled clinical trial testing sertraline as an
      antifungal medicine in combination with fluconazole for treatment of HIV-infected persons
      with AIDS and asymptomatic cryptococcal antigenemia (CrAg+).
    
  